Fact check: Can baking soda cure cancer? This is what we know
Tired of too many ads? go ad free now
But how much of it holds scientific weight? What has actually been studied, and what remains misunderstood?
Here are all the facts that we need to know to separate hope from hype and understand what baking soda can and cannot do when it comes to cancer.
The idea behind baking soda and cancer: Where did it begin?
The theory isn't just pulled from thin air. Solid tumours are known to create an acidic environment around themselves, something scientists call the
. This acidity plays a role in helping tumours grow, invade nearby tissues, and resist therapies.
Since baking soda, or sodium bicarbonate, is a natural base, the idea is that it could neutralise the acid, slow down tumour growth, or even stop it.
This idea first gained traction through lab experiments and animal
, where sodium bicarbonate appeared to reduce the acidic environment around cancer cells. In some cases, it made those cells more vulnerable to treatments like chemotherapy.
But here's where the caution bell rings loud—lab success doesn't automatically translate into real-world cures.
What current research really says: Promising, but not a standalone solution
Some recent
, especially in ovarian cancer models, have shown that sodium bicarbonate can reduce acidity, improve drug absorption, and even encourage immune responses that help fight cancer. For example:
When combined with a drug called Olaparib, sodium bicarbonate helped suppress certain cancer cell activities, including growth and spread. It also seemed to transform immune cells into types that are more aggressive against tumours. Researchers observed less oxidative stress (a process that helps cancer cells survive) in treated samples. But here's the important catch: these results were either in lab dishes (in vitro) or animal models (in vivo). There is no large-scale clinical trial yet that proves baking soda alone can treat or cure cancer in humans.
so far suggest this local use of sodium bicarbonate might help, not by curing the cancer, but by making it more vulnerable to existing treatments. It shows that the real power lies in combination, not in isolation.
Tired of too many ads? go ad free now
Still, experts agree: this is not a green light for DIY use or home treatments with baking soda. The method, dosage, and delivery are crucial, and none of these are safe to try outside a controlled medical setting.
Breast cancer symptoms, diagnosis and ways to treat it
Why baking soda alone is not the answer
Despite the hopeful headlines and occasional social media buzz, baking soda is not a magic bullet. Here's why:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
2 days ago
- Daily Mirror
'Doctors told me breast lump was blocked milk duct - then I got devastating news'
Barbara Jeffrey, 34, had just given birth when she noticed that something was wrong - and the lump her doctors thought was nothing serious turned out to be cancer A new mother who found a lump in her breast when breastfeeding was told it was a blocked milk duct - before finding out she had cancer. Barbara Jeffery, 34, had just given birth to Canada-Rose, who is now three, when she noticed the lump. After going to her GP and a breast clinic, she was told it was mastitis, which is when a blocked duct becomes inflamed. She explained: "They said it wasn't anything to be worried about, it wasn't dangerous … I had a lump the size of a golf ball, and it was growing and becoming more and more painful." The mum had it drained four times before further testing was done, and Barbara said that if they had done a biopsy then, 'we would have been in a very different position'. Eventually, an ultrasound, mammogram and tests found that she had grade 3 triple negative breast cancer. She said: "When they told me I had Canada-Rose on my lap. My husband Craig had stepped outside with our son, Hudson, who is autistic and was feeling dysregulated. I shouted through to him, 'Craig, I've got cancer,' and he phoned my sister in London.' Barbara was told that she had two tumours in her left breast which had spread to the lymph nodes in her armpit and the mammary chain down to the centre of her sternum. She began chemotherapy, radiotherapy, and also had a double mastectomy. Over time, Craig noticed that his wife was getting more forgetful. She recalled that on the evening of her daughter's first birthday, she got into bed and said she couldn't remember any part of the day. Barbara said: "That night we contacted my consultant, who's phenomenal. She put me through for a brain MRI, which found three tumours. I was 33 years old with a one-year-old and a three-year-old, being told I had stage 4 cancer and six to nine months to live." Further scans found an additional ten brain tumours. Despite being stable now, Barbara said she is under 'no illusion that it won't come back', adding: "It's like antibiotics - my body will get used to Olaparib, a chemotherapy drug which stops the cancer from growing, and it will become ineffective. I may need to go back for chemo or radiotherapy, or it may be that they can't do anything more. We're very aware that this is going to be life limiting." Her children are now four and three, and Barbara's hair loss during treatment was particularly hard for Hudson. "When I lost my hair he was devastated. He used it as a regulation tool and it was how he'd go to sleep - by twizzling my hair.' Barbara said that her message to pregnant women would be to 'know your normal' and if a doctor says you have mastitis, 'keep an eye on it'. She added: "The waiting times are killing people. They can't get enough people through treatment - they don't have the capacity to treat people in time to manage symptoms or save life.'
New York Post
30-05-2025
- New York Post
Groundbreaking new treatment for aggressive breast cancer has 100% survival rate
Hope is on the horizon for patients with aggressive, inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of combining chemotherapy with the targeted cancer drug olaparib before surgery. Every patient who received this protocol survived the critical three-year post-treatment period. Advertisement 3 BRCA cancers are notoriously aggressive and difficult to treat. Vasyl – The research, published in Nature Communications, suggests this preemptive, two-part approach could be the most effective plan of treatment for early-stage breast cancer linked to BRCA1 and BRCA2 gene mutations. Breast cancer or BRCA genes are present in every cell of the human body. When functioning, BRCA1 and BRCA2 repair DNA and prevent cancerous changes. However, when a mutation compromises these genes, cancer risk increases. Inheriting this damaged DNA can increase the risk for breast and ovarian cancer in women and breast and prostate cancer in men. Advertisement BRCA1 or BRCA2 genes are more common in young women, and these mutations increase cancer risk by as much as 84%. Six percent of all breast cancer patients carry BRCA gene mutations, but in patients under 45, roughly 12% carry the gene. BRCA cancers are notoriously aggressive and difficult to treat. In 2013, Angelina Jolie, who carries the faulty BRCA1 gene, made headlines when she underwent a preventative double mastectomy. As a result of the procedure, Jolie, who lost her own mother to breast cancer, saw her chances of developing breast cancer drop from 87 percent to less than 5 percent. Advertisement The current protocol for treating BRCA cancers includes shrinking the tumour using chemotherapy and immunotherapy, before removing it through surgery. 3 Angelina Jolie, who carries the faulty BRCA1 gene, underwent a preventative double mastectomy. Getty Images The first three years after surgery — when there is the greatest risk of relapse or death — are critical. The trial recruited patients from across the UK and aimed to test the efficacy of combining chemotherapy with olaparib before surgery and carefully timing when these treatments were administered. Advertisement 'It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer.' Professor Jean Abraham The study revealed that allowing a 48-hour 'gap' between chemotherapy and olaparib treatments led to more positive outcomes. Researchers believe this interval allows the patient's bone marrow to recover from chemo while leaving tumor cells receptive to olaparib. Olaparib, sold under the brand name Lynparza, is typically taken for 12 months post-surgery. However, trial patients took the tablets pre-surgery for a period of 12 weeks. The survival rate among the control group who received chemotherapy alone was 88%. Of these 45 patients, nine relapsed and six died within three years of surgery. In contrast, there was a 100% survival rate among the 39 patients who received chemotherapy followed by olaparib. Of this cohort, only one patient relapsed in the three years following surgery. 'It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer,' said trial lead Professor Jean Abraham. 3 Olaparib, sold under the brand name Lynparza, is typically taken for 12 months post-surgery. However, trial patients took the tablets pre-surgery for a period of 12 weeks. AstraZeneca Pharmaceuticals Advertisement 'We're incredibly excited about the potential of this new approach, as it's crucial that we find a way to treat and hopefully cure patients who are diagnosed with BRCA1 and BRCA2-related cancers.' Compared to current care protocols, the two-pronged approach of chemo and olaparib pre-surgery offers a more cost-effective and less toxic treatment for patients. Abrahams and his team are planning the next research phase, which will aim to replicate their results in a larger study. Advertisement They are hopeful their findings can and will be applied to treat other cancers caused by mutated BRCA genes, including some ovarian, prostate, and pancreatic cancers. Breast cancer is the most common cancer among US women after skin cancer. About 1 in 8 women will be diagnosed with breast cancer in their lifetime. Though breast cancer starts in a localized part of the breast tissue, it can spread to other areas of the body, significantly decreasing rates of survival. Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if the cancer is detected after the cancer cells have migrated, that number drops to 31%.
Time of India
13-05-2025
- Time of India
Fact check: Can baking soda cure cancer? This is what we know
Every now and then, a home remedy makes headlines with big promises. One such claim that's been circulating for years is that baking soda can cure cancer. It's an idea that has sparked debates, hope, and confusion. Tired of too many ads? go ad free now But how much of it holds scientific weight? What has actually been studied, and what remains misunderstood? Here are all the facts that we need to know to separate hope from hype and understand what baking soda can and cannot do when it comes to cancer. The idea behind baking soda and cancer: Where did it begin? The theory isn't just pulled from thin air. Solid tumours are known to create an acidic environment around themselves, something scientists call the . This acidity plays a role in helping tumours grow, invade nearby tissues, and resist therapies. Since baking soda, or sodium bicarbonate, is a natural base, the idea is that it could neutralise the acid, slow down tumour growth, or even stop it. This idea first gained traction through lab experiments and animal , where sodium bicarbonate appeared to reduce the acidic environment around cancer cells. In some cases, it made those cells more vulnerable to treatments like chemotherapy. But here's where the caution bell rings loud—lab success doesn't automatically translate into real-world cures. What current research really says: Promising, but not a standalone solution Some recent , especially in ovarian cancer models, have shown that sodium bicarbonate can reduce acidity, improve drug absorption, and even encourage immune responses that help fight cancer. For example: When combined with a drug called Olaparib, sodium bicarbonate helped suppress certain cancer cell activities, including growth and spread. It also seemed to transform immune cells into types that are more aggressive against tumours. Researchers observed less oxidative stress (a process that helps cancer cells survive) in treated samples. But here's the important catch: these results were either in lab dishes (in vitro) or animal models (in vivo). There is no large-scale clinical trial yet that proves baking soda alone can treat or cure cancer in humans. so far suggest this local use of sodium bicarbonate might help, not by curing the cancer, but by making it more vulnerable to existing treatments. It shows that the real power lies in combination, not in isolation. Tired of too many ads? go ad free now Still, experts agree: this is not a green light for DIY use or home treatments with baking soda. The method, dosage, and delivery are crucial, and none of these are safe to try outside a controlled medical setting. Breast cancer symptoms, diagnosis and ways to treat it Why baking soda alone is not the answer Despite the hopeful headlines and occasional social media buzz, baking soda is not a magic bullet. Here's why:
